ArticleJournal of diabetes investigation2024

Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management.

Takuma Yasuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.